What is the size of the Knee Hyaluronic Acid Injections market in 2023?

The Knee Hyaluronic Acid Injections market size is USD 2.2 billion in 2023.

What is the projected CAGR at which the Knee Hyaluronic Acid Injections market is expected to grow at?

The Knee Hyaluronic Acid Injections market is expected to grow at a CAGR of 5.2% (2024-2033).

List the segments encompassed in this report on the Knee Hyaluronic Acid Injections market?

Market.US has segmented the Knee Hyaluronic Acid Injections market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product the market has been segmented into Single Injection, Three Injection, Five Injection. By End-Use the market has been segmented into Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Others. By Application the market has been segmented into Osteoarthritis, Cartilage Repair, Other Knee Joint Disorders.

List the key industry players of the Knee Hyaluronic Acid Injections market?

Sanofi, Anika Therapeutics Inc. (DePuy Synthes Inc.), Seikagaku Corporation, Zimmer Biomet, Institut Biochimique SA (Bioventus LLC), Fidia Farmaceutici S.p.A, Meiji Seika Pharma Co. Ltd. (OrthogenRx), Ferring B.V., Viatrus Inc., Hanmi Pharm Co. Ltd. (Teva Pharmaceuticals Industries Ltd.), Chugai Pharmaceuticals Co. Ltd., Haohai Biological Technology, Hunan Jingfeng Pharmaceutical Co. Ltd. and Other Key Players.

Which region is more appealing for vendors employed in the Knee Hyaluronic Acid Injections market?

North America is expected to account for the highest revenue share of 37.8% and boasting an impressive market value of USD 0.83 billion. Therefore, the Knee Hyaluronic Acid Injections industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Knee Hyaluronic Acid Injections?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Knee Hyaluronic Acid Injections Market.

Global Knee Hyaluronic Acid Injections Market Analysis By Product (Single Injection, Three Injection, Five Injection), By End-Use (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Others), By Application (Osteoarthritis, Cartilage Repair, Other Knee Joint Disorders), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 84542
Number of Pages: 247
Format:

- Sanofi Company Profile
- Anika Therapeutics Inc. (DePuy Synthes Inc.)
- Seikagaku Corporation
- Zimmer Biomet
- Institut Biochimique SA (Bioventus LLC)
- Fidia Farmaceutici S.p.A
- Meiji Seika Pharma Co. Ltd. (OrthogenRx)
- Ferring B.V.
- Viatrus Inc.
- Hanmi Pharm Co. Ltd. (Teva Pharmaceuticals Industries Ltd.)
- Chugai Pharmaceuticals Co. Ltd.
- Haohai Biological Technology
- Hunan Jingfeng Pharmaceutical Co. Ltd.

Related Reports

Our Clients

Report ID 84542
Published Date Jan 2024
Rating
- ★★★★★
  
  ★★★★★
- (50)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible